Biomed | NXTGEN Hightech

Biotechnologie is belangrijk voor een sterke, concurrerende en toekomstbestendige economie. Hiermee kunnen we voorkomen dat we te veel afhankelijk worden van andere landen. Denk bijvoorbeeld aan het ontwikkelen van planten die beter bestand zijn tegen droogte, zodat we ook in de toekomst genoeg voedsel kunnen verbouwen. Nederland heeft al een goede positie: we hebben veel kennis en er zijn veel bedrijven actief in biotechnologie. Om mondiaal tot de kopgroep te behoren, moeten we duidelijk hebben wat we willen bereiken met biotechnologie. Daarom heb ik samen met staatssecretaris Chris Jansen het initiatief genomen tot een rijksbrede visie biotechnologie, die vandaag is aangeboden aan de Tweede Kamer. Ons doel is een sterk systeem waarin kennis wordt ontwikkeld, gedeeld en toegepast. Om biotechnologie te laten groeien, is het belangrijk dat er genoeg ruimte is voor innovatie, onderzoek en investeringen. Ook moet er een goede markt zijn in Nederland. We kiezen er daarom voor om onze innovatiemiddelen slimmer in te zetten, zodat ideeën sneller de markt bereiken. Het is belangrijk dat nationale en Europese regelgeving aansluit op de nieuwste wetenschappelijke kennis en er in Europa een gelijk speelveld is. Zo kan biotechnologie de Nederlandse economie nu en in de toekomst versterken. Lees hier meer over de rijksbrede visie biotechnologie ⤵️ https://lnkd.in/e-Eby5Kz Fleur Agema | Sophie Hermans | Eppo Bruins | Minister van Onderwijs, Cultuur en Wetenschap | Jean Rummenie | Vincent Karremans 

June 3rd | Matchmaking Event > High-Tech Systems and Materials for Biosensing, Bionanotechnology & Biohybrid Kidneys Are you ready to be part of revolutionary initiatives in the field of biosensing, bionanotechnology, and biohybrid kidneys? We invite you to join us at the matchmaking event on June 3rd at Villa Jongerius in Utrecht. Learn more about the NWO Call NXTGEN Hightech and the LSH-TKI PPP program Biohybrid Kidney XB and discover how they can help you boost your innovation. This event is specifically tailored for companies and academic researchers with expertise in: #Biosensing, #Biomaterials, Processing technologies (e.g., rapid #prototyping, #spinning, #3D #printing), #Biomimicking / #Bioactive materials for #hemocompatible coating, #Cellproduction / differentiation / preservation, #Bionanotechnologies (e.g., for synthetic #cells), Quality control systems for cell viability and transport function, In silico modeling Is your company interested in contributing to revolutionary biomedical therapies? This event provides a unique platform to meet potential partners and explore collaborative opportunities. For more information & registration please visit: https://lnkd.in/efXjMUJU Nierstichting RegMed XB NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek) Health~Holland International imec the Netherlands UMC Utrecht Universiteit Utrecht University of Twente High Tech NL Jasper M. Boomker Sabine Middendorp Juliette van den Dolder Edwin Roovers NXTGEN Hightech

Funding opportunity for collaborations with NXTGEN Biomed! The second call within the National Growth Fund programme NXTGEN Hightech is now open, offering an exciting opportunity to extend and establish collaborations in biomedical manufacturing technology and other high-tech domains. This is a fantastic chance for researchers, companies, and organisations to come together and drive innovation in the Netherlands. To support consortium building, NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek) and NXTGEN Hightech are hosting a matchmaking event on 14 May 2025. Ingrid Relou Sabine Middendorp Massimo Mastrangeli Wim van den Broek Wouter Beenker, PhD Karin Gerritsen

Check out this opportunity to participate in the public consultation organized by EMA to gather feedback on current regulatory testing requirements and 3Rs principles for medicine development.

Pitch your company to investors and key players in Life Sciences & Health! This is your opportunity to showcase your company to key investors, corporate leaders, and decision-makers in the Life Sciences & Health sector at the Health~Holland Global Investor Forum and Innovation for Health on April 2 -3, 2025. Gain visibility, attract potential funding, and build valuable connections that could accelerate your business. Only 30 pitching spots are available, and with more than 60% already booked, now is the time to secure your place! https://lnkd.in/eQ_A3AQu The start-up package includes: • A pitching slot at the Global Investor Forum • The opportunity to schedule one-on-one meetings with investors and industry leaders via partneringOne platform EBD Group • The possibility to be selected as a finalist and pitch at Innovation for Health (I4H) • The possibility of winning the I4H Start-Up Award, sponsored by Axon Lawyers and F-INSTITUTE • A Pitch Training session and expert feedback to refine your presentation before the contest The program will provide insights on key topics essential for start-up growth, including securing funding, partnering with large corporations, navigating investments and R&D, and strategic approaches to intellectual property and commercialization. You can find more details here: https://lnkd.in/e3nGCEQE So far, the confirmed investors are: Aglaia Oncology Funds, Apollo Health Ventures, BGV (BioGeneration Ventures), Bioqube Ventures, Brabantse Ontwikkelings Maatschappij (BOM), Brightlands Venture Partners, Capricorn Partners, Catalyze Group, Catalyze Capital, Curie Capital BV, Droia Ventures Flerie, Forbion, Forty51 Ventures, Gilde Healthcare, Inkef, InnovationQuarter, Invest International, Invest-NL, Johnson & Johnson, M Ventures , Myosotis Investments BV, NextGen Ventures, Novalis Biotech, Oost NL, ROM Utrecht Region, Thuja Capital, Utrecht Holdings Seed Fund and V-Bio Ventures. Find more about these companies via this link: https://lnkd.in/eeX3_Bqp Spaces are filling up fast— register today and join us on April 2-3 to pitch your company to top investors and leaders! Register now: https://lnkd.in/eQ_A3AQu #innovation #lifesciences #netherlands

Good to see this strong support for Organ-on-Chip!

Last chance to register for the economic LSH mission to Japan! 🇯🇵 🕦 Deadline: Wednesday, February 26 Active in the LSH sector in the fields of #RegenerativeMedicine, #DigitalHealthcare, #HealthyAging, or #SportsandVitality? Sign up for our Life Sciences & Health (LSH) mission to Tokyo and Osaka to explore opportunities! As one of the largest economies in the world, Japan offers unmatched opportunities for innovation and collaboration. This mission takes place during the 'Health and Well-being' theme week at the World Expo 2025 and you will also visit the Japan Health trade fair. All the details and registration can be found here: https://lnkd.in/eqUXDHrf NLExpo2025 - Netherlands participation at Expo 2025 Osaka Kansai, Embassy of the Kingdom of the Netherlands in Japan, Rijksdienst voor Ondernemend Nederland (RVO), オランダ経済省 企業誘致局 (NFIA Japan), Ministerie van Economische Zaken, Netherlands Foreign Investment Agency, Ministerie van Buitenlandse Zaken, Ministerie van Volksgezondheid, Welzijn en Sport, Task Force Health Care (TFHC), Health~Holland

As part of the Cell Production Technology project (Biomed05), we are developing next-generation bioreactor technology, incorporating innovative sensor solutions for precise process control. One exciting aspect of this work is continuous monitoring of cell death—a crucial factor in optimising bioprocesses. Kate Belina, a PhD student at Technische Universiteit Eindhoven, has put together a fantastic and creative pitch on this topic. If you’re curious to learn more, check out her PhD pitch here: 🔗 https://lnkd.in/eEM7BDzW #Biosensor and #ProcessAnalyticalTechnology #BioprocessAnalytics #CellProduction, #Innovation, #BPM Wouter Beenker, PhD NXTGEN Hightech

Now available on our website! Our latest "5 Questions for" article, 'The Future of Organ-on-Chip: Innovation, Standardization and Collaboration' featuring insights from Andries van der Meer, a leading researcher at the University of Twente. In this piece, we delve into the importance of #standardization, the challenges and opportunities in the field, and the impact of the NXTGEN Hightech project. Discover how collaboration between academic institutions, companies, and regulatory bodies is driving innovation and implementation in the pharmaceutical industry. Read the full article here: https://lnkd.in/eKm_TGC2 #OrganOnChip #BiomedicalResearch #Innovation #Standardization  Edwin Roovers Sabine Middendorp Ingrid Relou Willem Endhoven Monika Hoekstra Massimo Mastrangeli

🚀 Proud to share that Nextkidney has secured the €2.5M EICA Award to revolutionize home hemodialysis with Neokidney! Excited for the next steps in bringing this life-changing innovation to kidney patients worldwide. Nextkidney #Innovation #KidneyHealth